These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 30866850)

  • 1. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images.
    Wu J; Liu A; Cui J; Chen A; Song Q; Xie L
    BMC Med Imaging; 2019 Mar; 19(1):23. PubMed ID: 30866850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
    Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
    Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
    Fan Y; Yu Y; Wang X; Hu M; Hu C
    BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of microvascular invasion in hepatocellular carcinoma patients with MRI radiomics based on susceptibility weighted imaging and T2-weighted imaging.
    Geng Z; Wang S; Ma L; Zhang C; Guan Z; Zhang Y; Yin S; Lian S; Xie C
    Radiol Med; 2024 Aug; 129(8):1130-1142. PubMed ID: 38997568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
    Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
    Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics-based distinction of small (≤2 cm) hepatocellular carcinoma and precancerous lesions based on unenhanced MRI.
    Gao X; Bian J; Luo J; Guo K; Xiang Y; Liu H; Ding J
    Clin Radiol; 2024 May; 79(5):e659-e664. PubMed ID: 38341345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
    Yang X; Yuan C; Zhang Y; Wang Z
    Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal Cancer].
    Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Texture-based classification of different single liver lesion based on SPAIR T2W MRI images.
    Li Z; Mao Y; Huang W; Li H; Zhu J; Li W; Li B
    BMC Med Imaging; 2017 Jul; 17(1):42. PubMed ID: 28705145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.
    Xi Z; Ye Y; Yang Y; He Y; Song Z; Ma Q; Zeng H; Shao G
    Abdom Radiol (NY); 2024 Jul; 49(7):2387-2400. PubMed ID: 39030402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
    Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
    Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of radiomics model based on dynamic contrast-enhanced magnetic resonance imaging in differentiation fat-poor angiomyolipoma from alpha-fetoprotein-negative hepatocellular carcinoma in the background of non-cirrhotic liver].
    Zhang Y; Zhao XT; Wang ML; Han LJ; Mao L; Li XL; Liang CH; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):196-200. PubMed ID: 35042288
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiomics Analysis on Noncontrast CT for Distinguishing Hepatic Hemangioma (HH) and Hepatocellular Carcinoma (HCC).
    Hu S; Lyu X; Li W; Cui X; Liu Q; Xu X; Wang J; Chen L; Zhang X; Yin Y
    Contrast Media Mol Imaging; 2022; 2022():7693631. PubMed ID: 35833080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of whole-tumor apparent diffusion coefficient map radiomics analysis in predicting early recurrence of solitary hepatocellular carcinoma ≤ 5 cm.
    Wang L; Feng B; Wang S; Hu J; Liang M; Li D; Wang S; Ma X; Zhao X
    Abdom Radiol (NY); 2022 Sep; 47(9):3290-3300. PubMed ID: 35776146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative analysis of hepatocellular carcinomas pathological grading in non-contrast magnetic resonance images].
    Gao F; Yan B; Zeng L; Wu M; Tan H; Hai J; Ning P; Shi D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Aug; 36(4):581-589. PubMed ID: 31441258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.